B Capital announced it has been selected as a registered venture capital firm under the Agency for Medical Research and Development’s Strengthening Program for Pharmaceutical Startup Ecosystem, positioning the firm to expand its investment and commercialization efforts across Japan’s pharmaceutical and biotech startup landscape. The designation enables B Capital to invest in drug discovery...

  B Capital announced it has been selected as a registered venture capital firm under the Agency for Medical Research and Development’s Strengthening Program for Pharmaceutical Startup Ecosystem, positioning the firm to expand its investment and commercialization efforts across Japan’s pharmaceutical and biotech startup landscape. The designation enables B Capital to invest in drug discovery...

  B Capital announced it has been selected as a registered venture capital firm under the Agency for Medical Research and Development’s Strengthening Program for Pharmaceutical Startup Ecosystem, positioning the firm to expand its investment and commercialization efforts across Japan’s pharmaceutical and biotech startup landscape. The designation enables B Capital to invest in drug discovery...